Y-mAbs Therapeutics Stock (NASDAQ: YMAB) stock price, news, charts, stock research, profile.
Open | $12.63 |
Close | $12.53 |
Volume / Avg. | 128.58K / 334.59K |
Day Range | 12.24 - 12.74 |
52 Wk Range | 4.60 - 20.90 |
Market Cap | $549.85M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | 11.63% |
Days to Cover | 16.12 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Y-mAbs Therapeutics (NASDAQ:YMAB) through any online brokerage.
Other companies in Y-mAbs Therapeutics’s space includes: Valneva (NASDAQ:VALN), Voyager Therapeutics (NASDAQ:VYGR), Korro Bio (NASDAQ:KRRO), Larimar Therapeutics (NASDAQ:LRMR) and PepGen (NASDAQ:PEPG).
There is no analysis for Y-mAbs Therapeutics.
Y-mAbs Therapeutics has a consensus price target of $17.73.
The stock price for Y-mAbs Therapeutics (NASDAQ: YMAB) is $12.53 last updated July 26, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Y-mAbs Therapeutics.
Y-mAbs Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Y-mAbs Therapeutics.
Y-mAbs Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.